Continuous glucose monitoring for the masses is here. Are we ready for it?

Anne Thompson

akstanwyck

More stories by Anne

‘Nosferatu’: How to Make a Robert Eggers Movie, with Help from Mel Brooks and Chris Columbus

In the Photorealistic

September 5 Director Tim Fehlbaum Didn

Time：2024-08-26 13:08

By making continuous glucose monitors available without a prescription, manufacturers will be targeting a market of nearly 100 million potential users.Dexcom

By Katie Palmer and Lizzy Lawrence

Aug. 26, 2024

NEW YORK — Glucose tracking is the future, Dexcom executives gushed at a glitzy launch event for their new, over-the-counter continuous glucose monitor on Wednesday evening. Surrounded by champagne, new celebrity ambassador and “Parks and Rec” actress Retta, and a mini-pickleball court, CEO Kevin Sayer declared victory.

“Dexcom has literally created an industry, and now it’s time to create a much broader revolution in health care,” Sayer told attendees.

Over the past 25 years, continuous glucose monitors have changed the shape of diabetes care. The devices, which measure blood glucose using a sensor that pierces the very top layer of skin, have helped people with type 1 diabetes avoid life-threatening dips at night, and improved blood glucose control for insulin-using diabetes patients.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe Log In chronic disease, diabetes, health tech, Medical devices, STAT+ Submit a correction requestReprints

Katie Palmer
Health Tech Correspondent
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses.
Lizzy Lawrence
FDA Reporter
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter.